Protzman W P, Jacobs S L, Minnicozzi M, Oden E M, Kelsey D K
J Immunol Methods. 1984 Dec 31;75(2):317-23. doi: 10.1016/0022-1759(84)90115-7.
A radioimmunologic technique has been developed to screen sera of persons receiving human alpha-2 interferon for the presence of specific antibodies to alpha-2 interferon. The method is sensitive and easy to perform. It tests the ability of the sera to neutralize alpha-2 interferon and prevent the interferon from being detected by an immunoradiometric assay. The results obtained using this technique are in good agreement with an anti-viral, cytopathic effect assay. Using the immunological technique, the sera from more than 1000 individuals who had received different doses of alpha-2 interferon by one or more of various routes of administration were tested. Twenty-five sera representing 14 individuals gave a positive or possibly positive reaction in the assay. Three of the 14 individuals were positive prior to receipt of alpha-2 interferon. Another 3 had reverted to negative when tested a few months later. Of the remaining 8, only 4 developed titers greater than 100 neutralizing units/ml. Hence approximately 1% of the alpha-2 interferon recipients may have produced neutralizing antibodies.
已开发出一种放射免疫技术,用于筛查接受人α-2干扰素治疗的人的血清中是否存在针对α-2干扰素的特异性抗体。该方法灵敏且易于操作。它检测血清中和α-2干扰素并阻止干扰素被免疫放射分析检测到的能力。使用该技术获得的结果与抗病毒细胞病变效应分析结果高度一致。利用该免疫技术,对1000多名通过一种或多种不同给药途径接受不同剂量α-2干扰素的个体的血清进行了检测。代表14名个体的25份血清在检测中呈阳性或可能呈阳性反应。14名个体中有3名在接受α-2干扰素之前呈阳性。另外3名在几个月后检测时转为阴性。在其余8名个体中,只有4名个体产生的效价大于100中和单位/毫升。因此,大约1%的α-2干扰素接受者可能产生了中和抗体。